🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Motor fluctuations are identified as the most challenging symptoms by parki...
Status
Not Yet Recruiting
Location
CHU Toulouse
Start Date
2025-05-01
Trial ID
NCT06817200
Treatments Being Tested
This study is designed to determine whether memantine is an effective treat...
Status
Completed
Location
USC
Start Date
2004-04
Trial ID
NCT00300716
Treatments Being Tested
Ataxia-Telangiectasia A-T is a neurodegenerative disorder of the cerebellum...
Status
Completed
Location
Sheba Medical Center
Start Date
2008-11
Trial ID
NCT00950196
Treatments Being Tested
The aim of this study is to evaluate if memantine or dextromethorphan gave ...
Status
Completed
Location
CHU Clermont-Ferrand
Start Date
2012-05
Trial ID
NCT01602185
About 65% of patients with severe Alzheimer's Disease (AD) will have sympto...
Status
Completed
Location
The Forves Norris MDA/ALS Research Center
Start Date
2004-09
Trial ID
NCT00097916
Treatments Being Tested
This study will attempt to study the effect of memantine, on memory, and mo...
Status
Completed
Location
Rush University Medical Center
Start Date
2011-12
Trial ID
NCT01372449
Traditionally amantadine is used at the beginning of Parkinson Disease (PD)...
Status
Completed
Location
CHG Aix en Provence
Start Date
2012-03-04
Trial ID
NCT01538329
Treatments Being Tested
As the US population ages, the prevalence of dementia is increasing, and Al...
Status
Active Not Recruiting
Location
University of Virginia
Start Date
2021-10-11
Trial ID
NCT05063851
Treatments Being Tested
Tp determine the effect of IV amantadine on dopaminergic-drug-resistant fre...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2011-04
Trial ID
NCT01313819
Treatments Being Tested
Alzheimer's disease (AD) is the main cause of dementia. At present, AD is i...
Status
Unknown
Location
Multiple Locations
Start Date
2022-07-01
Trial ID
NCT05430867
Treatments Being Tested